Lamivudine‐based maintenance antiretroviral therapies in patients living with HIV ‐1 with suppressed HIV RNA : derivation of a predictive score for virological failure-Reference-Cited by-同舟云学术

Lamivudine‐based maintenance antiretroviral therapies in patients living with HIV ‐1 with suppressed HIV RNA : derivation of a predictive score for virological failure

Published:2019-06-25 Issue:9 Volume:20 Page:624-627
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Borghetti A¹^ORCID,Moschese D²,Cingolani A¹²,Baldin G²^ORCID,Speziale D³,Ciccullo A²^ORCID,Lombardi F²,Emiliozzi A²^ORCID,Belmonti S²^ORCID,Antinori A⁴,Cauda R¹²,Di Giambenedetto S¹²

Affiliation:

1. Fondazione Policlinico Agostino Gemelli IRCCS Infectious Diseases Unit Rome Italy

2. Institute of Clinical Infectious Diseases Catholic University of the Sacred Heart Rome Italy

3. Institute of Microbiology Catholic University of the Sacred Heart Rome Italy

4. UOC Immunodeficienze Virali Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani‐IRCCS Rome Italy

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.12759

Reference10 articles.

1. Current and emerging two-drug approaches for HIV-1 therapy in ART-naïve and ART-experienced, virologically suppressed patients

2. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxilfumarate and emtricitabine in antiretroviral‐naive adults with HIV‐1 infection (GEMINI‐1 and GEMINI‐2): week 48 results from two multicentre, double‐blind, randomised, non‐inferiority, phase 3 trials;Cahn P;Lancet,2018

3. Individual patient data meta-analysis of randomized controlled trials of dual therapy with a boosted PI plus lamivudine for maintenance of virological suppression: GeSIDA study 9717

4. Efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multicentre cohort of patients with suppressed HIV-1 replication

5. Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of treatment efficacy after switching to dolutegravir-lamivudine dual therapy in people living with HIV;African Health Sciences;2022-10-28

2. Predictors of Virological Failure Among People Living with HIV Switching from an Effective First-Line Antiretroviral Regimen;AIDS Research and Human Retroviruses;2022-02-10

3. Quantification of Total HIV DNA as a Marker to Measure Viral Reservoir: Methods and Potential Implications for Clinical Practice;Diagnostics;2021-12-24

4. Prevalence and determinants of virological failure, genetic diversity and drug resistance among people living with HIV in a minority area in China: a population-based study;BMC Infectious Diseases;2020-06-23

5. Shall We Dance? Extending TANGO’s Results to Clinical Practice;Clinical Infectious Diseases;2020-03-21